0 antall prosjekter

BIOTEK2021-Bioteknologi for verdiskaping

3rd International NTNU Symposium on Clinical Biomarkers of Cancer

In June 2021, we will organize the third conference in a series devoted to clinical biomarkers of cancer. The conference was scheduled for 2020, but unfortunately had to be postponed due to the pandemic. The two previous meetings in 2016 and 2018 were highly successful with outstanding internatio...

Tildelt: kr 99 999

Prosjektperiode: 2021-2021

Sted: Trøndelag - Trööndelage

GAVEFORST-Gaveforsterkningsordningen

Gave fra K.G. Jebsen til NTNU, til myelomforskning

...

Tildelt: kr 0,89 mill.

Prosjektperiode: 2016-2017

Sted: Trøndelag - Trööndelage

FRIMEDBIO-Fri prosj.st. med.,helse,biol

Hepatocyte Growth Factor in the Pathogenesis of Multiple Myeloma

Since our publications in 1996 showing that malignant plasma cells (MM cells) usually express both HGF and its receptor c-Met, a growing number of reports have implicated HGF/c-Met in the biology of MM. For instance, high levels of HGF in serum of MM pati ents predict a bad prognosis and correlat...

Tildelt: kr 3,3 mill.

Prosjektperiode: 2009-2012

Sted: Trøndelag - Trööndelage

FRIBIO-Biologi og biomedisin

Hepatocyte Growth Factor in the Pathogenesis of Multiple Myeloma

Since our original publications in 1996 showing that malignant plasma cells (MM cells) usually express both HGF and its receptor c-Met, a growing number of reports have implicated HGF/c-Met in the biology of MM. For instance, high levels of HGF in serum o f an MM patient predict a bad prognosis a...

Tildelt: kr 1,8 mill.

Prosjektperiode: 2006-2008

Sted: Trøndelag - Trööndelage